YUANLI(SH:603217)2022-04-27 16:00Financial Performance - The company's operating revenue for Q1 2022 reached ¥759,576,850.78, representing a year-on-year increase of 65.49%[4] - The net profit attributable to shareholders was ¥134,123,573.68, reflecting a growth of 63.59% compared to the same period last year[4] - The basic earnings per share (EPS) was ¥1.031, which is an increase of 63.65% year-on-year[4] - The total profit of ¥158,976,278.18 for Q1 2022, up from ¥96,038,418.12 in Q1 2021[18] - Net profit for Q1 2022 was ¥134,123,573.68, representing a 63.5% increase from ¥81,986,121.00 in Q1 2021[18] Cash Flow and Liquidity - The net cash flow from operating activities amounted to ¥94,222,119.50, showing an increase of 87.27% from the previous year[4] - Cash flow from operating activities in Q1 2022 was ¥94,222,119.50, an increase from ¥50,312,358.78 in Q1 2021[21] - The total cash and cash equivalents at the end of the period reached approximately $690.20 million, up from $424.14 million, reflecting a significant increase of about 62.7%[23] - The net increase in cash and cash equivalents for the period was approximately $322.78 million, compared to $264.67 million in the previous period, representing an increase of about 21.9%[22] Assets and Liabilities - Total assets at the end of the reporting period were ¥3,268,852,630.15, up 6.39% from the end of the previous year[5] - As of March 31, 2022, the company's total assets amounted to RMB 3,268,852,630.15, an increase from RMB 3,072,594,755.90 at the end of 2021, reflecting a growth of approximately 6.4%[13] - The company's total liabilities reached RMB 551,599,116.67, up from RMB 499,380,928.32, indicating an increase of approximately 10.5%[15] - Total current liabilities were reported at RMB 529,042,579.52, an increase from RMB 481,043,017.27, reflecting a growth of about 10.0%[15] Research and Development - The company's R&D expenses increased by 66.11% year-on-year, indicating a significant investment in new product development[7] - Research and development expenses for Q1 2022 totaled ¥32,109,433.66, up 66.1% from ¥19,329,671.10 in Q1 2021[17] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 10,537[9] - The equity attributable to shareholders remained stable at RMB 130,129,000.00, unchanged from the previous period[15] Other Financial Metrics - The weighted average return on equity rose to 5.07%, an increase of 1.51 percentage points compared to the previous year[4] - The company reported a decrease in other comprehensive income, with a value of -RMB 357,537.68 compared to -RMB 318,061.40 in the previous period[15] - Other comprehensive income after tax for Q1 2022 was -¥39,476.28, slightly improved from -¥47,830.86 in Q1 2021[19] Operational Costs - Operating costs for Q1 2022 were ¥604,786,502.70, up 63.8% from ¥368,959,810.85 in Q1 2021[17] - The company experienced a 130.02% increase in management expenses due to the stock incentive plan costs for 2021[7] Inventory and Accounts Receivable - The company reported a 44.25% increase in accounts receivable, attributed to the rise in operating revenue[6] - Accounts receivable increased to RMB 200,194,754.90 from RMB 138,785,453.70, representing a growth of about 44.4%[13] - Inventory levels rose to RMB 426,931,454.63, compared to RMB 358,687,549.21, marking an increase of approximately 19.0%[14] Investment Activities - The net cash inflow from investment activities was approximately $228.98 million, compared to $215.05 million in the previous period, indicating a growth of about 6.5%[22] - The cash outflow from investment activities totaled approximately $459.48 million, compared to $777.67 million in the previous period, showing a decrease of about 41%[22] - The cash inflow from investment activities was approximately $688.46 million, down from $992.72 million, indicating a decline of about 30.6%[22] Accounting Standards - The company did not apply the new accounting standards for the current year, as indicated in the report[23] Market Strategy - The company has not disclosed any new product developments or market expansion strategies during this reporting period[12]